PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP
Clinical trial NCT02401061 · TERMINATED
Trial details
- NCT number
- NCT02401061
- Sponsor
- Protalex, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2019-03-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.